Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(33.3%)
N/A
1(33.3%)
Phase 4
1(33.3%)
3Total
Phase 2(1)
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07576842Not ApplicableNot Yet Recruiting

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

Role: collaborator

NCT07516548Not Yet Recruiting

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

Role: collaborator

NCT02369406Phase 2Active Not Recruiting

Early Infant HIV Treatment in Botswana

Role: collaborator

NCT06436274Phase 4Active Not Recruiting

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

Role: collaborator

All 4 trials loaded